沉默的浪潮:一种拉布多解诱导的高热血病病例
Moath Fateh1, Tariq Albweitel1, Ahmad Odeh1
1Faculty of Medicine, University of Jordan, Amman, Jordan.
The American journal of case reports
|December 25, 2025
概括
轮骨髓溶解最初可能导致水平较低,但后来可能导致严重的高血症,因为肌肉组织释放. 这一案例突出显示了通过液体,利尿剂和denosumab成功治疗延迟高血症.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 毒理学 毒理学 毒理学
背景情况:
- 是一种重要的细胞外阴,对生理功能至关重要.
- 拉布多溶解通常会导致低血症,原因是在受损的肌肉中结合.
- 罕见地,体溶解会导致高血症,特别是在急性损伤后的康复期间.
研究的目的:
- 报告一个罕见的拉布多米解析后延迟严重高血症病例.
- 强调认识到这种延迟的诊断和管理模式的重要性.
- 在这个背景下讨论高血症的成功治疗.
主要方法:
- 一个48岁的男性患者的病例报告,他患有拉布地质溶解,急性损伤和随后的高血症.
- 最初的治疗包括带切割和脏替代疗法.
- 过血症的治疗包括静脉注射液体,利尿剂和苏马布.
主要成果:
- 患者在最初的狂犬病诊断六周后出现严重的高血症 (血清15.3毫克/分升).
- 用液体,利尿剂和代诺苏马布治疗使水平正常化,症状消失.
- 该病例出现特别迟缓的发病和异常高的水平.
结论:
- 轮骨髓溶解可以表现为初始的低血症,其次是延迟的高血症,原因是死肌肌肉释放的.
- 及时识别和管理延迟高血症至关重要.
- 静脉注射液体,利尿剂,和denosumab是有效的管理这种情况.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
319
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
319
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
346
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
346
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Nephrotic Syndrome II : Assessment and Medical Management
179
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
179
Nephrotic Syndrome I : Introduction
460
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
460
Hemodialysis II: Procedure and Complications
558
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
558


